AVGO vs. JNJ: Broadcom vs. Johnson & Johnson Stock Comparison

Company Profile

Broadcom (AVGO) is classified in the Information Technology sector (Semiconductors & Semiconductor Equipment), whereas Johnson & Johnson (JNJ) belongs to Health Care (Pharmaceuticals, Biotechnology & Life Sciences) — their GICS classifications point to very different parts of the market.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Broadcom (AVGO) has an aggressive beta of 1.50, indicating higher sensitivity to broad-market moves, while Johnson & Johnson (JNJ) is defensive at 0.21 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Both Broadcom (AVGO) at 44.25% and Johnson & Johnson (JNJ) at 20.02% sit in the top peer quartile for ROE, suggesting each generates more profit from shareholders’ equity than typical industry peers.

For every dollar of sales, both Broadcom (AVGO) at 42.94% and Johnson & Johnson (JNJ) at 16.20% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

Both Broadcom (AVGO) at 54.31% and Johnson & Johnson (JNJ) at 25.74% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

Profitability Metrics

Growth

Both Broadcom (AVGO) at 23.87% and Johnson & Johnson (JNJ) at 6.05% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Both companies show strong earnings momentum, but Broadcom (AVGO) at 287.80% is the standout with EPS growth above its industry range; Johnson & Johnson (JNJ) at 90.50% also sits in the top quartile.

Growth Metrics

Financial Strength

Broadcom (AVGO) at 2.50 keeps current ratio within its industry’s typical mid-range, while Johnson & Johnson (JNJ) at 1.02 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for JNJ.

Both Broadcom (AVGO) at 0.60 and Johnson & Johnson (JNJ) at 0.55 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

Financial Strength Metrics

Dividends

Broadcom (AVGO) at 0.89% earns its spot in the top quartile of its industry’s yields; Johnson & Johnson (JNJ) at 1.94% is past the top of its own peer range — territory where a dividend-safety check matters more than the headline number.

Both pay out more than their industries’ typical bands, and JNJ more so: Broadcom (AVGO) at 32.44% sits above the band, while Johnson & Johnson (JNJ) at 80.12% exceeds every peer in its group.

Dividend Metrics

Valuation

Both Broadcom (AVGO) at 37.51 and Johnson & Johnson (JNJ) at 41.92 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.

Johnson & Johnson (JNJ) at 6.69 is priced about in line with its industry on P/S ratio, while Broadcom (AVGO) at 15.73 sits in the pricier quartile — AVGO costs more per dollar of sales.

Both Broadcom (AVGO) at 14.06 and Johnson & Johnson (JNJ) at 8.16 carry a premium to book value versus peers, sitting in the upper P/B ratio quartile of their industries.

Valuation Metrics